過敏性鼻炎：現狀及挑戰 干細胞糾正免疫失衡，根源性治療過敏性鼻炎 干細胞治療過敏性鼻炎的臨床進展
參考文獻：
[1] 張彭,謝洋,關佳瑞.過敏性鼻炎患者報告結局評價量表的現狀與思考[J].中醫雜志,2021,62(22):1944-1951.
https://kns.cnki.net/kns8/defaultresult/index
[2] 任振勇,潘萬旗.過敏性鼻炎治療思路探討[J].山西中醫,2021,37(11):1-3.
https://kns.cnki.net/kns8/defaultresult/index
[3] Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011 Dec 17;378(9809):2112-22.
https://pubmed.ncbi.nlm.nih.gov/21783242/
[4] Goodwin M, Sueblinvong V, Eisenhauer P, Ziats NP, LeClair L, Poynter ME, Steele C, Rincon M, Weiss DJ. Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells. 2011 Jul;29(7):1137-48.
https://pubmed.ncbi.nlm.nih.gov/21544902/
[5] Zhao N, Liu Y, Liang H, Jiang X. Bone marrow-derived mesenchymal stem cells reduce immune reaction in a mouse model of allergic rhinitis. Am J Transl Res. 2016 Dec 15;8(12):5628-5636.
https://pubmed.ncbi.nlm.nih.gov/28078033/
[6] Fu QL, Chow YY, Sun SJ, Zeng QX, Li HB, Shi JB, Sun YQ, Wen W, Tse HF, Lian Q, Xu G. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Allergy. 2012 Oct;67(10):1215-22.
https://pubmed.ncbi.nlm.nih.gov/22882409/
[7] Fan XL, Zeng QX, Li X, Li CL, Xu ZB, Deng XQ, Shi J, Chen D, Zheng SG, Fu QL. Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients. Stem Cell Res Ther. 2018 Jun 19;9(1):170.
https://pubmed.ncbi.nlm.nih.gov/29921316/
編輯：小果果，轉載請注明出處：http://www.448371.com/cells/gxb/7414.html
免責聲明：本站所轉載文章來源于其他平臺，主要目的在于分享行業相關知識，傳遞當前最新資訊。圖片、文章版權均屬于原作者所有，如有侵權，請及時告知，我們會在24小時內刪除相關信息。
說明：本站所發布的案例均摘錄于文獻，僅用于科普干細胞與再生醫學相關知識，不作為醫療建議。
微信掃一掃 
支付寶掃一掃 